Purpose: To test the efficacy of an intravitreal dexamethasone implant in patients with recalcitrant macular edema secondary to retinal vein occlusion. Methods: A retrospective chart review was performed for 18 patients with retinal vein occlusion who received multiple bevacizumab intravitreal injections before treatment with an intravitreal dexamethasone implant. Results: Two subgroups of bevacizumab-resistant patients were identified. Both subgroups responded to subsequent treatment with an intravitreal dexamethasone implant with an average reduction in central foveal thickness of 146.8 +/- 33.65 mu m. A visual acuity improvement of 0.26 +/- 0.07 (logarithm of minimal angle of resolution) was also noted. Intraocular pressure increased by an average of 3.33 +/- 0.66 mmHg and was managed by 1.0 +/- 0.5 topical drops. Conclusion: A subset of patients do not have resolution of macular edema after treatment with intravitreal bevacizumab. Such patients may respond to treatment with an intravitreal dexamethasone implant.
机构:
HanGil Eye Hosp, Dept Ophthalmol, Retina Ctr, Incheon, South KoreaHanGil Eye Hosp, Dept Ophthalmol, Retina Ctr, Incheon, South Korea
Moon, Byung Gil
Cho, Ah Ran
论文数: 0引用数: 0
h-index: 0
机构:
Seoul Shinsegae Eye Ctr, Uijongbu, South KoreaHanGil Eye Hosp, Dept Ophthalmol, Retina Ctr, Incheon, South Korea
Cho, Ah Ran
Kim, You Na
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaHanGil Eye Hosp, Dept Ophthalmol, Retina Ctr, Incheon, South Korea
Kim, You Na
Kim, June-Gone
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaHanGil Eye Hosp, Dept Ophthalmol, Retina Ctr, Incheon, South Korea
Kim, June-Gone
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2018,
38
(06):
: 1166
-
1174